Dolutegravir plus rilpivirine dual therapy in treating HIV-1 infection
Author:
Affiliation:
1. First Division of Infectious Diseases, ASST Fatebenefratelli-Sacco, Milano, Italy
2. School of Clinical Medicine, Faculty of Health Sciences, Whitwaterstrand University, Johannesburg, South Africa
Funder
None
Publisher
Informa UK Limited
Subject
Pharmacology (medical),Pharmacology,General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/14656566.2017.1417984
Reference70 articles.
1. Demographics of HIV and aging
2. Aging with HIV in the ART era
3. Cellular Senescence, Immunosenescence and HIV
4. Predictors of transitions in frailty severity and mortality among people aging with HIV
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Therapeutic drug monitoring and virological response at week 48 in a cohort of HIV‐1‐infected patients switching to dolutegravir/rilpivirine dual maintenance therapy (ANRS‐MIE‐BIRIDER study);British Journal of Clinical Pharmacology;2023-09-18
2. Direct and indirect cardiovascular and cardiometabolic sequelae of the combined anti-retroviral therapy on people living with HIV;Frontiers in Physiology;2023-03-27
3. Comparison of the design and methodology of Phase 3 clinical trials of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) and dolutegravir-based dual therapy (DTG) in HIV: a systematic review of the literature;Expert Review of Anti-infective Therapy;2022-11-27
4. Optimizing switching strategies to simplify antiretroviral therapy: the future of second-line from a public health perspective;AIDS;2021-12-15
5. Dolutegravir-based dual maintenance regimens combined with lamivudine/emtricitabine or rilpivirine: risk of virological failure in a real-life setting;Journal of Antimicrobial Chemotherapy;2021-10-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3